Abstract

The Administrative Core is requested to facilitate internal interactions among the PI, project leaders, core B, and theResearch Resource Technical Development Component at both on- and off-campus sites and with NIAID and otherCenters.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
3U19AI057330-05S1
Application #
7698926
Study Section
Special Emphasis Panel (ZAI1-PTM-I (M4))
Project Start
2008-05-20
Project End
2009-03-31
Budget Start
2008-05-20
Budget End
2009-03-31
Support Year
5
Fiscal Year
2008
Total Cost
$128,011
Indirect Cost

  Institution

Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215

  Publications

Walsh, Stephen R; Wilck, Marissa B; Dominguez, David J et al. (2013) Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. J Infect Dis 207:1888-97
Walsh, Stephen R; Seaman, Michael S; Grandpre, Lauren E et al. (2012) Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine 31:114-9
Seedhom, Mina O; Mathurin, Keisha S; Kim, Sung-Kwon et al. (2012) Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders. J Virol 86:6010-22
Zhang, Guang Lan; Lin, Hong Huang; Keskin, Derin B et al. (2011) Dana-Farber repository for machine learning in immunology. J Immunol Methods 374:18-25
Zhang, Guang Lan; DeLuca, David S; Keskin, Derin B et al. (2011) MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J Immunol Methods 374:53-61
Reinhold, Bruce; Keskin, Derin B; Reinherz, Ellis L (2010) Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap. Anal Chem 82:9090-9
Welsh, Raymond M; Che, Jenny W; Brehm, Michael A et al. (2010) Heterologous immunity between viruses. Immunol Rev 235:244-66
Wilck, Marissa B; Seaman, Michael S; Baden, Lindsey R et al. (2010) Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis 201:1361-70
Liu, Luzheng; Zhong, Qiong; Tian, Tian et al. (2010) Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16:224-7
Seaman, Michael S; Wilck, Marissa B; Baden, Lindsey R et al. (2010) Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J Infect Dis 201:1353-60

Showing the most recent 10 out of 20 publications